array:25 [
  "pii" => "S0001731021003720"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2020.04.021"
  "estado" => "S300"
  "fechaPublicacion" => "2022-03-01"
  "aid" => "2785"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2022;113:310-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S0001731022001387"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2022.02.013"
    "estado" => "S300"
    "fechaPublicacion" => "2022-03-01"
    "aid" => "2927"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T310-T312"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
      "titulo" => " RF-2019 Classification Criteria for Systemic Lupus Erythematosus"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "T310"
          "paginaFinal" => "T312"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "FR-Criterios de clasificaci&#243;n 2019 del lupus eritematoso sist&#233;mico"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Serra-Garc&#237;a, P&#46;J&#46; Barba, D&#46; Morgado-Carrasco"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Serra-Garc&#237;a"
            ]
            1 => array:2 [
              "nombre" => "P&#46;J&#46;"
              "apellidos" => "Barba"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Morgado-Carrasco"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001387?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000003/v2_202212210529/S0001731022001387/v2_202212210529/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0001731022001351"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2022.02.010"
    "estado" => "S300"
    "fechaPublicacion" => "2022-03-01"
    "aid" => "2924"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T306-T309"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
      "titulo" => " RF &#8211; Dermatology and the LGBTIQ&#43; Community"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "T306"
          "paginaFinal" => "T309"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "FR &#8211; La Dermatolog&#237;a y el colectivo LGTBIQ&#43;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "D&#46; Ramos-Rodr&#237;guez, J&#46; Boix-Vilanova, E&#46; Sendagorta"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Ramos-Rodr&#237;guez"
            ]
            1 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Boix-Vilanova"
            ]
            2 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Sendagorta"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001351?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000003/v2_202212210529/S0001731022001351/v2_202212210529/en/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:18 [
      "pii" => "S0001731022001387"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2022.02.013"
      "estado" => "S300"
      "fechaPublicacion" => "2022-03-01"
      "aid" => "2927"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2022;113:T310-T312"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
        "titulo" => " RF-2019 Classification Criteria for Systemic Lupus Erythematosus"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "T310"
            "paginaFinal" => "T312"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "FR-Criterios de clasificaci&#243;n 2019 del lupus eritematoso sist&#233;mico"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "L&#46; Serra-Garc&#237;a, P&#46;J&#46; Barba, D&#46; Morgado-Carrasco"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "L&#46;"
                "apellidos" => "Serra-Garc&#237;a"
              ]
              1 => array:2 [
                "nombre" => "P&#46;J&#46;"
                "apellidos" => "Barba"
              ]
              2 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Morgado-Carrasco"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001387?idApp=UINPBA000044"
      "url" => "/00017310/0000011300000003/v2_202212210529/S0001731022001387/v2_202212210529/en/main.assets"
    ]
  ]
  "es" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>"
    "titulo" => "FR-Criterios de clasificaci&#243;n 2019 del lupus eritematoso sist&#233;mico"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "310"
        "paginaFinal" => "312"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "L&#46; Serra-Garc&#237;a, P&#46;J&#46; Barba, D&#46; Morgado-Carrasco"
        "autores" => array:3 [
          0 => array:2 [
            "nombre" => "L&#46;"
            "apellidos" => "Serra-Garc&#237;a"
          ]
          1 => array:2 [
            "nombre" => "P&#46;J&#46;"
            "apellidos" => "Barba"
          ]
          2 => array:4 [
            "nombre" => "D&#46;"
            "apellidos" => "Morgado-Carrasco"
            "email" => array:1 [
              0 => "danielmorgado@yahoo.com.ar"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Departamento de Dermatolog&#237;a&#44; Hospital Cl&#237;nic de Barcelona&#44; Universitat de Barcelona&#44; Barcelona&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "RF-2019 Classification Criteria for Systemic Lupus Erythematosus"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">El lupus eritematoso sist&#233;mico &#40;LES&#41; es una enfermedad autoinmune sist&#233;mica con un amplio espectro de manifestaciones cl&#237;nicas e inmunol&#243;gicas&#44; y diagn&#243;stico complejo&#46; Los criterios clasificatorios de LES son esenciales para la homogeneizaci&#243;n de cohortes y la reproducibilidad de los ensayos cl&#237;nicos<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">En 2019&#44; la <span class="elsevierStyleItalic">European League Against Rheumatism</span> &#40;EULAR&#41; y el <span class="elsevierStyleItalic">American College of Rheumatology</span> &#40;ACR&#41; elaboraron nuevos criterios de clasificaci&#243;n para el LES<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> &#40;EULAR&#47;ACR-2019&#41;&#44; con una mayor sensibilidad y especificidad respecto a los anteriores criterios ACR de 1997 &#40;ACR-1997&#41; y las <span class="elsevierStyleItalic">Systemic Lupus International Collaborating Clinics</span> del 2012 &#40;SLICC-2012&#41;&#46; La metodolog&#237;a utilizada incluy&#243; en la primera fase una revisi&#243;n sistem&#225;tica de la literatura<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a>&#44; un ejercicio Delphi con 145 expertos internacionales<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a>&#44; una cohorte de 616 pacientes con LES de inicio reciente y una encuesta en 339 individuos con LES&#46; En la segunda fase&#44; 19 expertos emplearon la t&#233;cnica de grupo nominal para reducir a 21 los criterios clasificatorios<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a>&#46; En la tercera fase se separaron los criterios en dominios cl&#237;nicos e inmunol&#243;gicos&#46; Para la ponderaci&#243;n de los criterios&#44; con una muestra representativa de pacientes con LES&#44; se compararon parejas de criterios mediante un an&#225;lisis de decisi&#243;n multicriterio&#46; La &#250;ltima fase de refinamiento y validaci&#243;n de criterios emple&#243; una cohorte de validaci&#243;n compuesta por 1&#46;270 individuos &#40;696 pacientes con LES y 574 controles con enfermedades simuladoras de LES&#41;&#46; Los nuevos criterios presentaron una sensibilidad y una especificidad del 96&#44;1&#37; y del 93&#44;4&#37;&#44; respectivamente&#44; representando una mejora en comparaci&#243;n con los criterios ACR-1997 y SLICC-2012<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a>&#44; lo que permite una mayor exactitud y un menor porcentaje de falsos positivos y negativos&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">La modificaci&#243;n de mayor relevancia introducida por EULAR&#47;ACR-2019 es la presencia de anticuerpos antinucleares &#40;ANA&#41; a t&#237;tulos<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80 &#40;medido en c&#233;lulas HEp-2 o equivalente&#41; como criterio indispensable&#44; lo que implica la exclusi&#243;n de aquellos pacientes con ANA persistentemente negativos&#46; Este criterio se basa en los resultados de una revisi&#243;n sistem&#225;tica que incluy&#243; a 13&#46;080 pacientes con LES&#44; en la que un t&#237;tulo de ANA<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80 demostr&#243; una sensibilidad del 97&#44;8&#37;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a>&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Adicionalmente&#44; se han redise&#241;ado los criterios cl&#237;nicos e inmunol&#243;gicos&#44; ahora subdivididos en 7 dominios cl&#237;nicos &#40;constitucional&#44; hematol&#243;gicos&#44; neuropsiqui&#225;tricos&#44; mucocut&#225;neos&#44; serosos&#44; musculoesquel&#233;ticos y renales&#41; y 3 dominios inmunol&#243;gicos &#40;anticuerpos antifosfolip&#237;dicos&#44; bajos niveles de complemento y anticuerpos espec&#237;ficos de LES&#41;&#46; Se ha incluido la fiebre inexplicada como criterio cl&#237;nico constitucional&#46; Dentro de cada dominio los diferentes criterios se han ponderado con valores de 2 a 10 seg&#250;n su peso relativo para el diagn&#243;stico de LES&#44; en base a la evidencia cient&#237;fica disponible&#46; Por tanto&#44; en base a los nuevos criterios&#44; el diagn&#243;stico de LES requiere la positividad de ANA<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80&#44; un criterio cl&#237;nico y una puntuaci&#243;n<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>10&#46; Los cambios en la ponderaci&#243;n permiten clasificar de LES a pacientes que presenten como &#250;nica manifestaci&#243;n cl&#237;nica nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">iii</span>-<span class="elsevierStyleSmallCaps">iv</span> y ANA positivos&#46; En cuanto a los criterios mucocut&#225;neos&#44; aunque un paciente presente diferentes tipos de manifestaciones cut&#225;neas t&#237;picas de LES&#44; &#250;nicamente puntuar&#225; la de mayor valor &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Por lo que&#44; de acuerdo con la nueva clasificaci&#243;n&#44; no es posible clasificar a un paciente de LES bas&#225;ndose &#250;nicamente en hallazgos mucocut&#225;neos&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Los nuevos criterios clasificatorios EULAR&#47;ACR-2019 para el LES presentan una mayor sensibilidad y especificidad&#44; e incluyen importantes modificaciones&#58; la positividad de los ANA como requisito indispensable&#44; nuevos criterios cl&#237;nicos y cambios en su ponderaci&#243;n&#44; con el fin de homogeneizar las cohortes de pacientes con LES&#44; e incluir individuos con menor tiempo de evoluci&#243;n de la enfermedad&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:1 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1590122"
          "palabras" => array:5 [
            0 => "Lupus eritematoso sist&#233;mico"
            1 => "Clasificaci&#243;n"
            2 => "Anticuerpos antinucleares"
            3 => "Lupus eritematoso cut&#225;neo"
            4 => "EULAR&#47;ACR 2019"
          ]
        ]
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">ANA&#58; anticuerpos antinucleares&#59; Anti-DNAds&#58; <span class="elsevierStyleItalic">anti-double stranded DNA antibodies</span>&#59; Anti-Sm&#58; anti-Smith&#59; Anti-&#946;2GP1&#58; <span class="elsevierStyleItalic">anti-beta 2 glycoprotein 1</span>&#59; EULAR&#47;ACR-2019&#58; clasificaci&#243;n 2019 de la <span class="elsevierStyleItalic">European League Against Rheumatism</span> y el <span class="elsevierStyleItalic">American College of Rheumatology</span> de lupus eritematoso sist&#233;mico&#59; LES&#58; lupus eritematoso sist&#233;mico&#46;</p>"
          "tablatextoimagen" => array:2 [
            0 => array:1 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " colspan="2" align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">EULAR&#47;ACR-2019Criterio indispensable&#58; <span class="elsevierStyleBold">ANA a t&#237;tulos</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">&#8805;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">1&#47;80</span>Criterios aditivos&#58; se requiere al menos un criterio cl&#237;nico y 10 puntos o m&#225;s<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></th></tr><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dominios cl&#237;nicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Puntuaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Constitucionales&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fiebre inexplicada<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>38&#44;5<span class="elsevierStyleHsp" style=""></span>&#778;C<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hematol&#243;gicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LeucopeniaTrombocitopeniaAnemia hemol&#237;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">344&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Neuropsiqui&#225;tricos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">DeliriumPsicosisConvulsiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">235&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mucocut&#225;neos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Alopecia no cicatricialUlceras oralesLupus cut&#225;neo subagudo o lupus eritematoso discoide<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a>Lupus cut&#225;neo agudo<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2246&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Serosos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Efusi&#243;n peric&#225;rdica o pleuralPericarditis aguda&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">56&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Musculoesquel&#233;ticos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Enfermedad articular&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Renales&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Proteinuria<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#44;5<span class="elsevierStyleHsp" style=""></span>&#956;g&#47;d&#237;aBiopsia renal con nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">ii</span> o <span class="elsevierStyleSmallCaps">v</span>Biopsia renal con nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">iii</span> o <span class="elsevierStyleSmallCaps">iv</span><span class="elsevierStyleSup">d</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4810&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
            ]
            1 => array:1 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dominios inmunol&#243;gicos</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Puntuaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anticuerpos antifosfolip&#237;dicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anticardiolipina o anti-&#946;2GP1 o anticoagulante l&#250;pico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prote&#237;nas del complemento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nivel bajo de C3 o C4Nivel bajo de C3 y C4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">34&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anticuerpos espec&#237;ficos de LES&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anti-DNAds o Anti-Sm&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
            ]
          ]
          "notaPie" => array:3 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Los criterios son acumulativos y no necesitan estar presentes simult&#225;neamente&#46; Dentro de cada dominio&#44; solo se contabiliza el criterio m&#225;s alto para la puntuaci&#243;n total&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">La fiebre inexplicada<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>38&#44;3<span class="elsevierStyleHsp" style=""></span>&#176;C es un nuevo criterio cl&#237;nico en esta clasificaci&#243;n&#46;</p>"
            ]
            2 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "c"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Definiciones&#58;</p> <p class="elsevierStyleNotepara" id="npar0020">a&#46; Lupus cut&#225;neo subagudo&#58; - Erupci&#243;n cut&#225;nea anular o papuloescamosa &#40;psoriasiforme&#41;&#44; generalmente fotodistribuida&#46;</p> <p class="elsevierStyleNotepara" id="npar0025">- Biopsia cut&#225;nea&#58; dermatitis vacuolar de interfase&#44; infiltrado linfohistioc&#237;tico perivascular y&#47;o mucinosis d&#233;rmica&#46;</p> <p class="elsevierStyleNotepara" id="npar0030">b&#46; Lupus eritematoso discoide&#58;</p> <p class="elsevierStyleNotepara" id="npar0035">- Lesiones cut&#225;neas eritematosas-viol&#225;ceas con cicatrizaci&#243;n atr&#243;fica&#44; despigmentaci&#243;n&#44; hiperqueratosis &#47; taponamiento folicular que produce alopecia cicatricial en el cuero cabelludo&#46;</p> <p class="elsevierStyleNotepara" id="npar0040">- Biopsia cut&#225;nea&#58; dermatitis vacuolar de interfase&#44; infiltrado linfohistioc&#237;tico perivascular y &#47; o perianexial&#46; Se pueden observar tapones foliculares en cuero cabelludo o dep&#243;sito de mucina en lesiones de larga evoluci&#243;n&#46;</p> <p class="elsevierStyleNotepara" id="npar0045">c&#46; Lupus cut&#225;neo agudo&#58;</p> <p class="elsevierStyleNotepara" id="npar0050">- Erupci&#243;n malar o erupci&#243;n maculopapular generalizada&#46;</p> <p class="elsevierStyleNotepara" id="npar0055">- Biopsia cut&#225;nea&#58; dermatitis vacuolar de interfase&#44; infiltrado linfohistioc&#237;tico perivascular&#44; a menudo con mucina d&#233;rmica&#46; Un infiltrado neutrof&#237;lico perivascular puede estar presente en fases tempranas</p> <p class="elsevierStyleNotepara" id="npar0060"><span class="elsevierStyleSup">d</span>La nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">iii</span> o <span class="elsevierStyleSmallCaps">iv</span> suma por s&#237; misma un puntaje de 10&#46; En presencia de ANA<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80 es suficiente para clasificar a un paciente con lupus eritematoso sist&#233;mico&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Criterios de lupus eritematoso sist&#233;mico seg&#250;n la nueva clasificaci&#243;n 2019 de la <span class="elsevierStyleItalic">European League Against Rheumatism</span> y el <span class="elsevierStyleItalic">American College of Rheumatology</span> &#40;EULAR&#47;ACR-2019&#41;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Distinctions between diagnostic and classification criteria&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Aggarwal"
                            1 => "S&#46; Ringold"
                            2 => "D&#46; Khanna"
                            3 => "T&#46; Neogi"
                            4 => "S&#46;R&#46; Johnson"
                            5 => "A&#46; Miller"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Care Res&#46;"
                        "fecha" => "2015"
                        "volumen" => "67"
                        "paginaInicial" => "891"
                        "paginaFinal" => "897"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2019 European League Against Rheumatism&#47;American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Aringer"
                            1 => "K&#46; Costenbader"
                            2 => "D&#46; Daikh"
                            3 => "R&#46; Brinks"
                            4 => "M&#46; Mosca"
                            5 => "R&#46; Ramsey-Goldman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Rheumatol &#40;Hoboken NJ&#41;&#46;"
                        "fecha" => "2019"
                        "volumen" => "71"
                        "paginaInicial" => "1400"
                        "paginaFinal" => "1412"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Performance of antinuclear antibodies for classifying systemic lupus erythematosus&#58; a systematic literature review and meta-regression of diagnostic data"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Leuchten"
                            1 => "A&#46; Hoyer"
                            2 => "R&#46; Brinks"
                            3 => "M&#46; Schoels"
                            4 => "M&#46; Schneider"
                            5 => "J&#46; Smolen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Care Res&#46;"
                        "fecha" => "2018"
                        "volumen" => "70"
                        "paginaInicial" => "428"
                        "paginaFinal" => "438"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Multi-center Delphi exercise reveals important key items for classifying systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Schmajuk"
                            1 => "B&#46;F&#46; Hoyer"
                            2 => "M&#46; Aringer"
                            3 => "S&#46;R&#46; Johnson"
                            4 => "D&#46;I&#46; Daikh"
                            5 => "T&#46; D&#246;rner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Care Res&#46;"
                        "fecha" => "2018"
                        "volumen" => "70"
                        "paginaInicial" => "1488"
                        "paginaFinal" => "1494"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methods of formal consensus in classification&#47;diagnostic criteria and guideline development"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Nair"
                            1 => "R&#46; Aggarwal"
                            2 => "D&#46; Khanna"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.semarthrit.2010.12.001"
                      "Revista" => array:6 [
                        "tituloSerie" => "Semin Arthritis Rheum&#46;"
                        "fecha" => "2011"
                        "volumen" => "41"
                        "paginaInicial" => "95"
                        "paginaFinal" => "105"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21420149"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011300000003/v2_202212210529/S0001731021003720/v2_202212210529/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "93537"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Foro de Residentes &#47; Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000003/v2_202212210529/S0001731021003720/v2_202212210529/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021003720?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Foro de Residentes
FR-Criterios de clasificación 2019 del lupus eritematoso sistémico
RF-2019 Classification Criteria for Systemic Lupus Erythematosus
L. Serra-García, P.J. Barba, D. Morgado-Carrasco
Corresponding author
danielmorgado@yahoo.com.ar

Autor para correspondencia.
Departamento de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España
Read
149407
Times
was read the article
20640
Total PDF
128767
Total HTML
Share statistics
 array:25 [
  "pii" => "S0001731021003720"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2020.04.021"
  "estado" => "S300"
  "fechaPublicacion" => "2022-03-01"
  "aid" => "2785"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2022;113:310-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S0001731022001387"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2022.02.013"
    "estado" => "S300"
    "fechaPublicacion" => "2022-03-01"
    "aid" => "2927"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T310-T312"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
      "titulo" => " RF-2019 Classification Criteria for Systemic Lupus Erythematosus"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "T310"
          "paginaFinal" => "T312"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "FR-Criterios de clasificaci&#243;n 2019 del lupus eritematoso sist&#233;mico"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Serra-Garc&#237;a, P&#46;J&#46; Barba, D&#46; Morgado-Carrasco"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Serra-Garc&#237;a"
            ]
            1 => array:2 [
              "nombre" => "P&#46;J&#46;"
              "apellidos" => "Barba"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Morgado-Carrasco"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001387?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000003/v2_202212210529/S0001731022001387/v2_202212210529/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0001731022001351"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2022.02.010"
    "estado" => "S300"
    "fechaPublicacion" => "2022-03-01"
    "aid" => "2924"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T306-T309"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
      "titulo" => " RF &#8211; Dermatology and the LGBTIQ&#43; Community"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "T306"
          "paginaFinal" => "T309"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "FR &#8211; La Dermatolog&#237;a y el colectivo LGTBIQ&#43;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "D&#46; Ramos-Rodr&#237;guez, J&#46; Boix-Vilanova, E&#46; Sendagorta"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Ramos-Rodr&#237;guez"
            ]
            1 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Boix-Vilanova"
            ]
            2 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Sendagorta"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001351?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000003/v2_202212210529/S0001731022001351/v2_202212210529/en/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:18 [
      "pii" => "S0001731022001387"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2022.02.013"
      "estado" => "S300"
      "fechaPublicacion" => "2022-03-01"
      "aid" => "2927"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2022;113:T310-T312"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
        "titulo" => " RF-2019 Classification Criteria for Systemic Lupus Erythematosus"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "T310"
            "paginaFinal" => "T312"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "FR-Criterios de clasificaci&#243;n 2019 del lupus eritematoso sist&#233;mico"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "L&#46; Serra-Garc&#237;a, P&#46;J&#46; Barba, D&#46; Morgado-Carrasco"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "L&#46;"
                "apellidos" => "Serra-Garc&#237;a"
              ]
              1 => array:2 [
                "nombre" => "P&#46;J&#46;"
                "apellidos" => "Barba"
              ]
              2 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Morgado-Carrasco"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001387?idApp=UINPBA000044"
      "url" => "/00017310/0000011300000003/v2_202212210529/S0001731022001387/v2_202212210529/en/main.assets"
    ]
  ]
  "es" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>"
    "titulo" => "FR-Criterios de clasificaci&#243;n 2019 del lupus eritematoso sist&#233;mico"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "310"
        "paginaFinal" => "312"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "L&#46; Serra-Garc&#237;a, P&#46;J&#46; Barba, D&#46; Morgado-Carrasco"
        "autores" => array:3 [
          0 => array:2 [
            "nombre" => "L&#46;"
            "apellidos" => "Serra-Garc&#237;a"
          ]
          1 => array:2 [
            "nombre" => "P&#46;J&#46;"
            "apellidos" => "Barba"
          ]
          2 => array:4 [
            "nombre" => "D&#46;"
            "apellidos" => "Morgado-Carrasco"
            "email" => array:1 [
              0 => "danielmorgado@yahoo.com.ar"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Departamento de Dermatolog&#237;a&#44; Hospital Cl&#237;nic de Barcelona&#44; Universitat de Barcelona&#44; Barcelona&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "RF-2019 Classification Criteria for Systemic Lupus Erythematosus"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">El lupus eritematoso sist&#233;mico &#40;LES&#41; es una enfermedad autoinmune sist&#233;mica con un amplio espectro de manifestaciones cl&#237;nicas e inmunol&#243;gicas&#44; y diagn&#243;stico complejo&#46; Los criterios clasificatorios de LES son esenciales para la homogeneizaci&#243;n de cohortes y la reproducibilidad de los ensayos cl&#237;nicos<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">En 2019&#44; la <span class="elsevierStyleItalic">European League Against Rheumatism</span> &#40;EULAR&#41; y el <span class="elsevierStyleItalic">American College of Rheumatology</span> &#40;ACR&#41; elaboraron nuevos criterios de clasificaci&#243;n para el LES<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> &#40;EULAR&#47;ACR-2019&#41;&#44; con una mayor sensibilidad y especificidad respecto a los anteriores criterios ACR de 1997 &#40;ACR-1997&#41; y las <span class="elsevierStyleItalic">Systemic Lupus International Collaborating Clinics</span> del 2012 &#40;SLICC-2012&#41;&#46; La metodolog&#237;a utilizada incluy&#243; en la primera fase una revisi&#243;n sistem&#225;tica de la literatura<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a>&#44; un ejercicio Delphi con 145 expertos internacionales<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a>&#44; una cohorte de 616 pacientes con LES de inicio reciente y una encuesta en 339 individuos con LES&#46; En la segunda fase&#44; 19 expertos emplearon la t&#233;cnica de grupo nominal para reducir a 21 los criterios clasificatorios<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a>&#46; En la tercera fase se separaron los criterios en dominios cl&#237;nicos e inmunol&#243;gicos&#46; Para la ponderaci&#243;n de los criterios&#44; con una muestra representativa de pacientes con LES&#44; se compararon parejas de criterios mediante un an&#225;lisis de decisi&#243;n multicriterio&#46; La &#250;ltima fase de refinamiento y validaci&#243;n de criterios emple&#243; una cohorte de validaci&#243;n compuesta por 1&#46;270 individuos &#40;696 pacientes con LES y 574 controles con enfermedades simuladoras de LES&#41;&#46; Los nuevos criterios presentaron una sensibilidad y una especificidad del 96&#44;1&#37; y del 93&#44;4&#37;&#44; respectivamente&#44; representando una mejora en comparaci&#243;n con los criterios ACR-1997 y SLICC-2012<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a>&#44; lo que permite una mayor exactitud y un menor porcentaje de falsos positivos y negativos&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">La modificaci&#243;n de mayor relevancia introducida por EULAR&#47;ACR-2019 es la presencia de anticuerpos antinucleares &#40;ANA&#41; a t&#237;tulos<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80 &#40;medido en c&#233;lulas HEp-2 o equivalente&#41; como criterio indispensable&#44; lo que implica la exclusi&#243;n de aquellos pacientes con ANA persistentemente negativos&#46; Este criterio se basa en los resultados de una revisi&#243;n sistem&#225;tica que incluy&#243; a 13&#46;080 pacientes con LES&#44; en la que un t&#237;tulo de ANA<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80 demostr&#243; una sensibilidad del 97&#44;8&#37;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a>&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Adicionalmente&#44; se han redise&#241;ado los criterios cl&#237;nicos e inmunol&#243;gicos&#44; ahora subdivididos en 7 dominios cl&#237;nicos &#40;constitucional&#44; hematol&#243;gicos&#44; neuropsiqui&#225;tricos&#44; mucocut&#225;neos&#44; serosos&#44; musculoesquel&#233;ticos y renales&#41; y 3 dominios inmunol&#243;gicos &#40;anticuerpos antifosfolip&#237;dicos&#44; bajos niveles de complemento y anticuerpos espec&#237;ficos de LES&#41;&#46; Se ha incluido la fiebre inexplicada como criterio cl&#237;nico constitucional&#46; Dentro de cada dominio los diferentes criterios se han ponderado con valores de 2 a 10 seg&#250;n su peso relativo para el diagn&#243;stico de LES&#44; en base a la evidencia cient&#237;fica disponible&#46; Por tanto&#44; en base a los nuevos criterios&#44; el diagn&#243;stico de LES requiere la positividad de ANA<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80&#44; un criterio cl&#237;nico y una puntuaci&#243;n<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>10&#46; Los cambios en la ponderaci&#243;n permiten clasificar de LES a pacientes que presenten como &#250;nica manifestaci&#243;n cl&#237;nica nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">iii</span>-<span class="elsevierStyleSmallCaps">iv</span> y ANA positivos&#46; En cuanto a los criterios mucocut&#225;neos&#44; aunque un paciente presente diferentes tipos de manifestaciones cut&#225;neas t&#237;picas de LES&#44; &#250;nicamente puntuar&#225; la de mayor valor &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Por lo que&#44; de acuerdo con la nueva clasificaci&#243;n&#44; no es posible clasificar a un paciente de LES bas&#225;ndose &#250;nicamente en hallazgos mucocut&#225;neos&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Los nuevos criterios clasificatorios EULAR&#47;ACR-2019 para el LES presentan una mayor sensibilidad y especificidad&#44; e incluyen importantes modificaciones&#58; la positividad de los ANA como requisito indispensable&#44; nuevos criterios cl&#237;nicos y cambios en su ponderaci&#243;n&#44; con el fin de homogeneizar las cohortes de pacientes con LES&#44; e incluir individuos con menor tiempo de evoluci&#243;n de la enfermedad&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:1 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1590122"
          "palabras" => array:5 [
            0 => "Lupus eritematoso sist&#233;mico"
            1 => "Clasificaci&#243;n"
            2 => "Anticuerpos antinucleares"
            3 => "Lupus eritematoso cut&#225;neo"
            4 => "EULAR&#47;ACR 2019"
          ]
        ]
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">ANA&#58; anticuerpos antinucleares&#59; Anti-DNAds&#58; <span class="elsevierStyleItalic">anti-double stranded DNA antibodies</span>&#59; Anti-Sm&#58; anti-Smith&#59; Anti-&#946;2GP1&#58; <span class="elsevierStyleItalic">anti-beta 2 glycoprotein 1</span>&#59; EULAR&#47;ACR-2019&#58; clasificaci&#243;n 2019 de la <span class="elsevierStyleItalic">European League Against Rheumatism</span> y el <span class="elsevierStyleItalic">American College of Rheumatology</span> de lupus eritematoso sist&#233;mico&#59; LES&#58; lupus eritematoso sist&#233;mico&#46;</p>"
          "tablatextoimagen" => array:2 [
            0 => array:1 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " colspan="2" align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">EULAR&#47;ACR-2019Criterio indispensable&#58; <span class="elsevierStyleBold">ANA a t&#237;tulos</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">&#8805;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">1&#47;80</span>Criterios aditivos&#58; se requiere al menos un criterio cl&#237;nico y 10 puntos o m&#225;s<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></th></tr><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dominios cl&#237;nicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Puntuaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Constitucionales&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fiebre inexplicada<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>38&#44;5<span class="elsevierStyleHsp" style=""></span>&#778;C<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hematol&#243;gicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LeucopeniaTrombocitopeniaAnemia hemol&#237;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">344&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Neuropsiqui&#225;tricos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">DeliriumPsicosisConvulsiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">235&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mucocut&#225;neos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Alopecia no cicatricialUlceras oralesLupus cut&#225;neo subagudo o lupus eritematoso discoide<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a>Lupus cut&#225;neo agudo<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2246&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Serosos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Efusi&#243;n peric&#225;rdica o pleuralPericarditis aguda&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">56&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Musculoesquel&#233;ticos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Enfermedad articular&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Renales&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Proteinuria<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#44;5<span class="elsevierStyleHsp" style=""></span>&#956;g&#47;d&#237;aBiopsia renal con nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">ii</span> o <span class="elsevierStyleSmallCaps">v</span>Biopsia renal con nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">iii</span> o <span class="elsevierStyleSmallCaps">iv</span><span class="elsevierStyleSup">d</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4810&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
            ]
            1 => array:1 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dominios inmunol&#243;gicos</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Puntuaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anticuerpos antifosfolip&#237;dicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anticardiolipina o anti-&#946;2GP1 o anticoagulante l&#250;pico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prote&#237;nas del complemento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nivel bajo de C3 o C4Nivel bajo de C3 y C4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">34&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anticuerpos espec&#237;ficos de LES&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Anti-DNAds o Anti-Sm&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
            ]
          ]
          "notaPie" => array:3 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Los criterios son acumulativos y no necesitan estar presentes simult&#225;neamente&#46; Dentro de cada dominio&#44; solo se contabiliza el criterio m&#225;s alto para la puntuaci&#243;n total&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">La fiebre inexplicada<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>38&#44;3<span class="elsevierStyleHsp" style=""></span>&#176;C es un nuevo criterio cl&#237;nico en esta clasificaci&#243;n&#46;</p>"
            ]
            2 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "c"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Definiciones&#58;</p> <p class="elsevierStyleNotepara" id="npar0020">a&#46; Lupus cut&#225;neo subagudo&#58; - Erupci&#243;n cut&#225;nea anular o papuloescamosa &#40;psoriasiforme&#41;&#44; generalmente fotodistribuida&#46;</p> <p class="elsevierStyleNotepara" id="npar0025">- Biopsia cut&#225;nea&#58; dermatitis vacuolar de interfase&#44; infiltrado linfohistioc&#237;tico perivascular y&#47;o mucinosis d&#233;rmica&#46;</p> <p class="elsevierStyleNotepara" id="npar0030">b&#46; Lupus eritematoso discoide&#58;</p> <p class="elsevierStyleNotepara" id="npar0035">- Lesiones cut&#225;neas eritematosas-viol&#225;ceas con cicatrizaci&#243;n atr&#243;fica&#44; despigmentaci&#243;n&#44; hiperqueratosis &#47; taponamiento folicular que produce alopecia cicatricial en el cuero cabelludo&#46;</p> <p class="elsevierStyleNotepara" id="npar0040">- Biopsia cut&#225;nea&#58; dermatitis vacuolar de interfase&#44; infiltrado linfohistioc&#237;tico perivascular y &#47; o perianexial&#46; Se pueden observar tapones foliculares en cuero cabelludo o dep&#243;sito de mucina en lesiones de larga evoluci&#243;n&#46;</p> <p class="elsevierStyleNotepara" id="npar0045">c&#46; Lupus cut&#225;neo agudo&#58;</p> <p class="elsevierStyleNotepara" id="npar0050">- Erupci&#243;n malar o erupci&#243;n maculopapular generalizada&#46;</p> <p class="elsevierStyleNotepara" id="npar0055">- Biopsia cut&#225;nea&#58; dermatitis vacuolar de interfase&#44; infiltrado linfohistioc&#237;tico perivascular&#44; a menudo con mucina d&#233;rmica&#46; Un infiltrado neutrof&#237;lico perivascular puede estar presente en fases tempranas</p> <p class="elsevierStyleNotepara" id="npar0060"><span class="elsevierStyleSup">d</span>La nefritis l&#250;pica clase <span class="elsevierStyleSmallCaps">iii</span> o <span class="elsevierStyleSmallCaps">iv</span> suma por s&#237; misma un puntaje de 10&#46; En presencia de ANA<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#47;80 es suficiente para clasificar a un paciente con lupus eritematoso sist&#233;mico&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Criterios de lupus eritematoso sist&#233;mico seg&#250;n la nueva clasificaci&#243;n 2019 de la <span class="elsevierStyleItalic">European League Against Rheumatism</span> y el <span class="elsevierStyleItalic">American College of Rheumatology</span> &#40;EULAR&#47;ACR-2019&#41;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Distinctions between diagnostic and classification criteria&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Aggarwal"
                            1 => "S&#46; Ringold"
                            2 => "D&#46; Khanna"
                            3 => "T&#46; Neogi"
                            4 => "S&#46;R&#46; Johnson"
                            5 => "A&#46; Miller"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Care Res&#46;"
                        "fecha" => "2015"
                        "volumen" => "67"
                        "paginaInicial" => "891"
                        "paginaFinal" => "897"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2019 European League Against Rheumatism&#47;American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Aringer"
                            1 => "K&#46; Costenbader"
                            2 => "D&#46; Daikh"
                            3 => "R&#46; Brinks"
                            4 => "M&#46; Mosca"
                            5 => "R&#46; Ramsey-Goldman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Rheumatol &#40;Hoboken NJ&#41;&#46;"
                        "fecha" => "2019"
                        "volumen" => "71"
                        "paginaInicial" => "1400"
                        "paginaFinal" => "1412"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Performance of antinuclear antibodies for classifying systemic lupus erythematosus&#58; a systematic literature review and meta-regression of diagnostic data"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Leuchten"
                            1 => "A&#46; Hoyer"
                            2 => "R&#46; Brinks"
                            3 => "M&#46; Schoels"
                            4 => "M&#46; Schneider"
                            5 => "J&#46; Smolen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Care Res&#46;"
                        "fecha" => "2018"
                        "volumen" => "70"
                        "paginaInicial" => "428"
                        "paginaFinal" => "438"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Multi-center Delphi exercise reveals important key items for classifying systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Schmajuk"
                            1 => "B&#46;F&#46; Hoyer"
                            2 => "M&#46; Aringer"
                            3 => "S&#46;R&#46; Johnson"
                            4 => "D&#46;I&#46; Daikh"
                            5 => "T&#46; D&#246;rner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Care Res&#46;"
                        "fecha" => "2018"
                        "volumen" => "70"
                        "paginaInicial" => "1488"
                        "paginaFinal" => "1494"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methods of formal consensus in classification&#47;diagnostic criteria and guideline development"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Nair"
                            1 => "R&#46; Aggarwal"
                            2 => "D&#46; Khanna"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.semarthrit.2010.12.001"
                      "Revista" => array:6 [
                        "tituloSerie" => "Semin Arthritis Rheum&#46;"
                        "fecha" => "2011"
                        "volumen" => "41"
                        "paginaInicial" => "95"
                        "paginaFinal" => "105"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21420149"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011300000003/v2_202212210529/S0001731021003720/v2_202212210529/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "93537"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Foro de Residentes &#47; Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000003/v2_202212210529/S0001731021003720/v2_202212210529/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021003720?idApp=UINPBA000044"
]
Article information
ISSN: 00017310
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 662 84 746
2024 October 7506 810 8316
2024 September 6530 764 7294
2024 August 4990 596 5586
2024 July 4693 500 5193
2024 June 4192 600 4792
2024 May 5110 771 5881
2024 April 5268 826 6094
2024 March 4148 653 4801
2024 February 4674 722 5396
2024 January 5051 517 5568
2023 December 3506 464 3970
2023 November 4830 735 5565
2023 October 5041 859 5900
2023 September 4890 789 5679
2023 August 3999 517 4516
2023 July 3709 589 4298
2023 June 4339 582 4921
2023 May 4813 599 5412
2023 April 3372 548 3920
2023 March 4028 740 4768
2023 February 3297 607 3904
2023 January 2497 572 3069
2022 December 1688 334 2022
2022 November 3950 729 4679
2022 October 3416 628 4044
2022 September 3481 616 4097
2022 August 2623 568 3191
2022 July 2148 478 2626
2022 June 2083 597 2680
2022 May 2673 609 3282
2022 April 1918 489 2407
2022 March 1709 445 2154
2022 February 996 229 1225
2022 January 531 158 689
2021 December 119 56 175
2021 November 142 93 235
2021 October 145 167 312
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?